This powder is mixed with a suitable diluent, such as bacteriostatic water or sterile water, to create an injectable solution
In contrast, IV therapy allows for 100% bioavailability, ensuring that the body receives an optimal dose
GHK-Cu has not been approved for any therapeutic use in humans by the United States Food and Drug Administration (FDA), nor by any of its international regulatory counterparts
Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancer
Brown E, Wilton MM, Sprung VS, Harrold JA, Halford JCG, Stancak A, Burgess M, Howarth E, Umpleby AM, Kemp GJ, et al
10.1016/j.biochi.2015.04.014 Biochimie